HOUSTON, July 16 /PRNewswire-FirstCall/ -- Cyberonics, Inc. today announced that the Demipulse(TM) and Demipulse Duo(TM) Generators for use in Vagus Nerve Stimulation (“VNS”) Therapy were approved by the United States Food and Drug Administration (“FDA”) for commercial release.
